ARVINAS, INC. Earnings Per Share (Diluted)
ARVINAS, INC. (ARVN) reported Earnings Per Share (Diluted) of $2.58 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-04
- ARVINAS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $2.58.
- ARVINAS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.90, a 178.95% decline year-over-year.
- ARVINAS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$1.04.
- ARVINAS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.48.
- ARVINAS, INC. earnings per share, diluted for fiscal 2025 was -$1.14.
- ARVINAS, INC. earnings per share, diluted for fiscal 2024 was -$2.77.
- ARVINAS, INC. earnings per share, diluted for fiscal 2023 was -$6.62.
- ARVINAS, INC. earnings per share, diluted for fiscal 2022 was -$5.31.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.58 10-Q · filed 2026-08-04 | $1.70 10-Q · filed 2026-08-04 | $0.68 derived: net income ÷ weighted average shares · filed 2026-08-04 | $0.14 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | -$0.90 10-Q · filed 2026-05-11 | -$1.94 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$2.38 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$3.22 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.49 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.33 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.14 10-K · filed 2026-02-24 |
| 2025-09-30 | -$0.48 10-Q · filed 2025-11-05 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.18 10-Q · filed 2025-11-05 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | -$0.84 10-Q · filed 2026-08-04 | $0.30 10-Q · filed 2026-08-04 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | $1.14 10-Q · filed 2026-05-11 | $0.52 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-05-11 |
| 2024-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.77 10-K · filed 2026-02-24 |
| 2024-09-30 | -$0.68 10-Q · filed 2025-11-05 | -$1.17 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$2.14 10-Q · filed 2025-11-05 | -$4.45 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-06-30 | -$0.49 10-Q · filed 2025-08-06 | -$1.46 10-Q · filed 2025-08-06 | -$3.80 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$4.99 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-03-31 | -$0.97 10-Q · filed 2025-05-01 | -$3.37 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$4.62 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$5.90 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-12-31 | -$2.52 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$3.79 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$5.07 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$6.62 10-K · filed 2026-02-24 |
| 2023-09-30 | -$1.18 10-Q · filed 2024-10-30 | -$2.43 derived: net income ÷ weighted average shares · filed 2024-10-30 | -$3.97 10-Q · filed 2024-10-30 | -$5.52 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-06-30 | -$1.25 10-Q · filed 2024-07-30 | -$2.78 10-Q · filed 2024-07-30 | -$4.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$5.59 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-03-31 | -$1.54 10-Q · filed 2024-05-07 | -$3.10 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$4.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$5.66 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-12-31 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.80 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$4.12 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$5.31 10-K · filed 2025-02-11 |
| 2022-09-30 | -$1.24 10-Q · filed 2023-11-07 | -$2.56 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$3.76 10-Q · filed 2023-11-07 | -$4.76 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-06-30 | -$1.32 10-Q · filed 2023-08-08 | -$2.51 10-Q · filed 2023-08-08 | -$3.52 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$4.47 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-03-31 | -$1.20 10-Q · filed 2023-05-05 | -$2.20 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$3.15 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$4.18 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2021-12-31 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.95 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.97 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$3.82 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.94 10-Q · filed 2022-11-09 | -$1.97 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$2.81 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$1.03 10-Q · filed 2022-08-04 | -$1.87 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$0.84 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$3.02 10-K · filed 2023-02-23 | |||
| 2019-12-31 | -$2.13 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |